WASHINGTON (Aug. 13, 2020) — Fingolimod, an FDA-approved immunosuppressive drug used to treat multiple sclerosis flare-ups, may be used to block HIV infection and reduce the latent reservoir. Researchers at the George Washington University (GW) published their novel findings in PLOS Pathogens.
MS Drug May be Used to Inhibit HIV Infection and Reduce Latent Reservoir
Latest News
Dr. Michael I. Bukrinsky, a Professor in GW's Department of Microbiology, Immunology, and Tropical Medicine, has co-authored a new review titled "Maladaptive trained immunity in viral infections" that was published in the Journal of Clinical Investigation (JCI).
Congratulations to Paprika Berry, Pedro Gazzinelli and Jada Covington (a PhD student in the IBS program - former rotating student) from the Gazzinelli lab, for advancing to the Top 5 in the GW New Venture Competition in the Healthcare track! Their innovative project, Weigh2Dose, also earned them…
Researchers at the George Washington University (GW) School of Medicine and Health Sciences (SMHS), in collaboration with colleagues in France and Germany, have developed a model organism from a genetically modified parasitic worm to better study neglected tropical disease.